About Collplant
Collplant is a company based in Ness Ziona (Israel) founded in 2004.. Collplant has raised $16.3 million across 10 funding rounds from investors including Ami Sagi, Invesco and Alpha Capital Partners. The company has 57 employees as of December 31, 2024. Collplant offers products and services including rhCollagen, Collink.3D Bioinks, and Dermal Fillers. Collplant operates in a competitive market with competitors including Revance Therapeutics, CELLINK, Hugel, Dermavant and Sol-Gel Technologies, among others.
- Headquarter Ness Ziona, Israel
- Employees 57 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Collplant Biotechnologies Ltd.
-
Annual Revenue
$515 K-95.3as on Dec 31, 2024
-
Net Profit
$-16.61 M-136.63as on Dec 31, 2024
-
EBITDA
$-16.21 M-152.93as on Dec 31, 2024
-
Total Equity Funding
$16.3 M (USD)
in 10 rounds
-
Latest Funding Round
$4.45 M (USD), Post-IPO
Feb 14, 2020
-
Investors
Invesco
& 4 more
-
Employee Count
57
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Collplant
Collplant is a publicly listed company on the NASDAQ with ticker symbol CLGN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Collplant
Collplant offers a comprehensive portfolio of products and services, including rhCollagen, Collink.3D Bioinks, and Dermal Fillers. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Recombinant human collagen for tissue regeneration applications
Bioinks for manufacturing tissues and organs
Regenerative products for aesthetic enhancements
Unlock access to complete
Unlock access to complete
Funding Insights of Collplant
Collplant has successfully raised a total of $16.3M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $4.45 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $4.5M
-
First Round
First Round
(01 Jun 2006)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2020 | Amount | Post-IPO - Collplant | Valuation |
investors |
|
| Sep, 2019 | Amount | Post-IPO - Collplant | Valuation |
investors |
|
| Nov, 2017 | Amount | Post-IPO - Collplant | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Collplant
Collplant has secured backing from 5 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include Ami Sagi, Invesco and Alpha Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A family office focused on private equity and investments.
|
Founded Year | Domain | Location | |
|
Pontifax Venture Capital is focused on life sciences investments.
|
Founded Year | Domain | Location | |
|
Investments are directed toward Israeli technology startups by Docor.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Collplant
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Collplant
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Collplant Comparisons
Competitors of Collplant
Collplant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revance Therapeutics, CELLINK, Hugel, Dermavant and Sol-Gel Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| domain | founded_year | HQ Location |
3D bioprinters and bioinks are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Therapeutics in aesthetics are developed, including botulinum toxin products.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
|
|
| domain | founded_year | HQ Location |
Skin care products are developed and manufactured by SkinMedica.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Collplant
Frequently Asked Questions about Collplant
When was Collplant founded?
Collplant was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Where is Collplant located?
Collplant is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
Is Collplant a funded company?
Collplant is a funded company, having raised a total of $16.3M across 10 funding rounds to date. The company's 1st funding round was a Post-IPO of $2M, raised on Jun 01, 2006.
How many employees does Collplant have?
As of Dec 31, 2024, the latest employee count at Collplant is 57.
What is the annual revenue of Collplant?
Annual revenue of Collplant is $515K as on Dec 31, 2024.
What does Collplant do?
The company was founded in 2004 in Ness Ziona, Israel, within the biotechnology sector. Plant-derived collagen and recombinant proteins are produced via a transgenic plant system for medical applications. Recombinant type I human collagen is generated for use in tissue repair, ortho-biologics, wound care, and 3D bioprinting. A dedicated 3D bioprinting division was established in 2017 to support organ and tissue fabrication.
Who are the top competitors of Collplant?
Collplant's top competitors include Revance Therapeutics, Dermavant and Sol-Gel Technologies.
What products or services does Collplant offer?
Collplant offers rhCollagen, Collink.3D Bioinks, and Dermal Fillers.
Is Collplant publicly traded?
Yes, Collplant is publicly traded on NASDAQ under the ticker symbol CLGN.
Who are Collplant's investors?
Collplant has 5 investors. Key investors include Ami Sagi, Invesco, Alpha Capital Partners, Pontifax Venture Capital, and Docor.
What is Collplant's ticker symbol?
The ticker symbol of Collplant is CLGN on NASDAQ.